Latest / The Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix It / 445. Breakthroughs in Anti-Aging: Senolytics and Cellular Health Revealed
Transcript
- 0:00Welcome to the Thyroid Fixer podcast. I'm your host, Dr. Amy, and we're diving deep into the world of hormones, especially for all you fierce women in perimenopause and menopause and anyone dealing with hypothyroidism. If you're struggling with weight gain, you feel like shedding those pounds is an impossible feat. If you're dealing with plummeting energy levels, gut-wrenching fatigue, or a libido that seems to have left town, then you're in the right place.
- 0:25And don't even get me started on the hair loss. If these symptoms are sounding all too familiar, you sound your tribe. Welcome. Because my goal is to educate, empower, and shake up your world. I want you to embrace every inch of that badass woman that you truly are. So if you're ready to dive in and fix things, let's get started.
- 0:48Greg, thank you so much for joining me today. We are going to be talking about a topic that I have not yet discussed on the show yet. And it's a big long word that maybe if you're listening, you've heard this word, but you're like, what does it mean and what's in it for me? So when we're talking about cellular senescence, say that five times fast, cellular senescence, essentially, I want you to explain it, Greg, but it's when we're looking at aging,
- 1:17which we all are looking at aging. If you're listening to this, you're looking at aging. And we're getting older every day, every minute, every hour. We have to think about not the here and now, but what's to come. Maybe it's to come in a week, or maybe we're looking down the pipe at 10 years from now.
- 1:35What does our life look like? What do our bodies look like? And right now in this moment is the time to start thinking about aging and thinking about what you can do and implement into your life to slow down the aging process, to improve it, to live like a badass when you're 50, 60, 70, 80.
- 1:53and be healthy and strong and feel good and look good. But we have to do things now. We can't put a Band-Aid on it when we're 70 years old and falling apart and our skin's hanging down to our ankles. We have to do things now to prevent that. And this is where this whole topic that we're gonna get into today
- 2:12of cellular senescence and autophagy and aging and senolytics, how they can help. That's what we're diving into. So if you haven't heard of this term yet, just strap in for the ride. We're going to dive deep. So Greg, are you ready to go for this? Yeah, absolutely. You teed it off well. Okay. Well, then I'm just going to hand it over to you for the question of what is cellular senescence and why should we even care? Okay.
- 2:40Yeah. So like stepping back, there's a framework for aging that you probably know of, and maybe some listeners have heard of called the Hallmarks of Aging. Yeah. So this was proposed about 10 years ago, updated again in 2023. And what these people put together was...
- 2:57a framework or a model saying, okay, whether we're looking at worms, flies, mice, monkeys, or humans, these things all seem to occur in common with the aging process and seem to underlie that process. And that one of those 12 is called cellular senescence, what you led into.
- 3:14And cellular cells, senescence, same root word as senile, you know, it has to do with basically aging, right? So a simple way to think is like, okay, these are aged cells, right? They're old cells. So that wouldn't be too far off the mark. And one of the things to keep in mind is that, you know, while we're aging, our cells are also aging. And many of the cells we had at age 20 will have been lived their life, died off, been replaced with daughter and son cells, you know, many times along the way.
- 3:44the road. And if you Googled it, you'd see on average, like a cell in a human lives for seven years. And that average is crazily misleading. And by that, I mean, the neurons in our brain, those last a lifetime. We never get new neurons, right? What we have, we have to keep good care of. Cells in our heart tissue, on average, will live about four decades. So we don't turn those off over many times. Cells in the liver will turn over about once every one to three years.
- 4:14Skin cells will slough off. Some of those are sloughing off even as we're speaking right now. So cells live, born, live their lives and die, but at varying rates depending on the tissue. But at any given point in time, you can think of like the majority of our cells are probably like the equivalent. The story I told to our head of marketing at one point was a gardening story because she's an avid gardener. And I said, okay, well, think of like plants in your garden. Yeah.
- 4:41Go out today, you look at a plant, all the leaves are vibrant green, super healthy plant. Think of that as the leaves are like the cells in our tissues, and that's a healthy tissue, whether the liver or muscles, fat. All the leaves are green.
- 4:56Now you go out a week later and you see, oh, there's a couple of yellowing leaves on this plant. Well, that's not great, right? The plant's stressed, you know, maybe too much sun, not enough water, nearby pests, you name it. Think of that as a senescent cell, right? One that's, because it's so stressed, it's starting to age prematurely in a sense. And then what ideally should happen on that plant is the yellowing leaf will fall off the plant and make room for new growth.
- 5:23And if that doesn't happen, then a good gardener will periodically come and prune it away, right, to make room for new growth. And so think of those yellowing leaves as kind of the equivalent of senescent cells, right? They're stressed cells that somewhere before they've died off have become so stressed that we...
- 5:43an active program, for lack of a better way to describe it, that prevents them from dividing and making new cells or in our analogy, new leaves. And so ideally, just like on the plant, they should fall off the plant. And that process is called apoptosis.
- 6:00which comes from a Greek word that literally means falling off in the sense that a leaf falls off a tree. So it makes sense, right? That's what should happen at the end of the life cycle of any of our cells. So in the liver, one to three years after they've worn, done their job, that those cells will go through this natural falling off process and be replaced.
- 6:18So what happens with synapses cells is they're prematurely stressed and they resist that falling off process. So bad cells floating around, just kind of stressed out and angry. Yeah. Yeah. And then, you know, what happens is we age is more and more accumulate. So like each week you go and check on that plant, there's more yellow leaves.
- 6:40And at some point that leaf will just struggle, right? It doesn't have enough healthy leaves to stay healthy. And meanwhile, the unhealthy ones are sucking up all the nutrients and other resources, right? So that's a way to think about senescent cells. There are these types of stress cells that occur starting even at a young age, but accumulate more and more the older we get.
- 7:05And then sometimes people will hear the analogy of a zombie cell as a way to describe them. And that's because of this idea, okay, they're not creating new cells, right? They're too stressed. We don't want to make copies of them. So, you know, a healthy live cell will make offspring when it needs to, right? It'll divide. So they're not quite alive because they don't do that, but they're resisting this falling off process. So they're not going through cell death. So they're stuck in this zombie area between.
- 7:34The two, right? They're not fully alive. They're not dead. They're resisting that, and they're not allowed to do this. And then the other reason you hear that is especially the types of senescent cells that accumulate when we get older, secrete all kinds of compounds into the environment around them. So that's, scientists would say, the microenvironment.
- 7:54But just think of like, again, going back to our plant analogy, right? If you have yellowing leaves and don't prune them off, they tend to attract pasts. They tend to basically make nearby leaves also yellow, right? Rather than, you know, a leaf on the other side of the plant. So senescent cells with these things, they spit out into the environment surround them can cause stress on otherwise healthy cells and cause them to become new senescent cells, right? So that's- Just like a zombie biting other people, causing-
- 8:23Causing them to turn into zombies. I get it now. Okay. Yeah. So that's, and so what happens for a variety of reasons, it's like a snowball rolling downhill as we get older, that senescent cells don't just accumulate slowly and gradually. It's almost like they hit a tipping point and then explode upwards.
- 8:41So if we were to look at, you know, tissues in a very old mouse or rat, as an example, we would see crazily high amounts of these stress senescent cells compared to a young also rat. And humans would be the same. It's just we don't look at humans much because you have to do tissue biopsies to look at senescent cells. There's no indirect way to really test for them.
- 9:04Well, and I was going to say, as we're aging, we can obviously see it on our face and we can see the changes in our skin and our body, but we can't really see what's inside. So we tend to almost forget the fact that these zombie cells are walking around wreaking havoc with other cells. And then that brings us into cancer, dementia, diseases of aging and the like.
- 9:29Yeah. So one of the things I think is a framework to think of, and I think your lead off teed this up and you probably didn't intend to. And we all know of life expectancy, right? So if you Google life expectancy, maybe you'll see like in the US, men live on average to 77, women to 79, somewhere in that ballpark.
- 9:47Um, but that's again, like that average skews reality because all the people that died really young are added in to that average. So a better way is like, okay, people that make it to 60, how long on average do they live? Right. So that's usually life expectancy at 60 is how you'd see that. And then also important is what would be like healthy years that you have after 60. So how
- 10:13You're vital. You can go to the gym. You can do, you know, play with your grandkids, do all the things that are important to you, right? So that's the, I think of as healthy life expectancy after 60. And this was a study that was based on 2019 data, but it came out in the last year. But what they found is on average in North America, people that made it to age 60 lived on average to about 82, right? So more, it's higher than the average life expectancy, right? Because it washes out all the young people that have died.
- 10:42But that about, you know, so say that's 21, 22 years on average, all of us listening, we want more than that, clearly, right? I do. I know you do. Yeah, right. But what they found is on average about the last seven of those were in fairly ill health, you know, assisted living or in other ways where people are really limited, right? And so there's a huge gap on average between even like what we might expect to live to and then the number of years that we can, you know, actually live our life the way we want. Yeah.
- 11:10And so there's this idea within the longevity space that's often called compression of mortality. But just think, like, we want to push that healthy window as close to the end as possible. Right? Like, we want to compress mortality into that really small space.
- 11:29small window. And this gets to what you started with, like to do that, you know, I think we need to do more and start doing it at a younger age. Otherwise, there's no shot. Once like the snowballs already gain momentum, then that's a really tough thing to do. And what, you know, people like you, and you know, I would put myself in this category, too, even though I'm much older than you, I started making good investments in my later years, starting by age 30.
- 11:58Yeah, to the best that I could think out and start to do things like let's, let's make good investments now. And the way I would think of it is the same as investing for our financial health. It's always good to make that investment. But I'd have been a lot smarter if I started making at age 22, as opposed to waiting to like, you know, I'm 62 now, like, it would have been silly to wait this long to start investing in that.
- 12:21financial wellness. And I think of the investment that your listeners, you know, want to make is the same one that I want to make, right? Like, like, what should I start doing? And when should I start doing it to, you know, make sure. On that note, when should we start? Like, what is a good age? Or at what age do we start to see these senescent cells happening and turning?
- 12:44Yeah, so that's a great question. The way we at Qualia think about it is categorize senescent cells as into two compartments, transient and lingering. During pregnancy, like embryo formation, there'll be waves of transient senescent cells that come in to shape...
- 13:01Fetal development, actually. And then they do their job and they vanish, right? They're transient. They just kind of pass through. And you would just say, okay, let's look at muscle biopsies in healthy 25-year-olds right after they ran a marathon or did some crazy intense exercise that's more than what they would normally do. We would see a bloom of senescent cells in those muscles immediately after that would act to call in the immune system and help regenerate and repair that damage.
- 13:30And if we looked a week later, they'd be gone. Pulled in, or we stress cells fundamentally, right, with what we did, but they didn't linger. They didn't do this resist apoptosis zombie step. But the lingering ones that we talk about with aging, what you would see if we did that same experiment correctly,
- 13:50crazy exercise for a young mouse did that same amount in an old, you'd see what would be the equivalent of an explosion of senescent cells. And a week later, two weeks later, they wouldn't have vanished. They'd have lingered in the tissues, right? And so when I think of senescent cells, it's specifically lingering ones, right? The ones that have outsmarted the immune system, which should find the stragglers or are resisting this natural falling off.
- 14:16That's why we need a gardener. But what happens is progressively over time, more and more linger. So in a 25-year-old, if there are any lingering ones, it would be so small in amount that the likelihood that they're causing any problem is super low. Doesn't mean they wouldn't be, but I tend to think of many things as having a threshold, where as long as it's below that threshold, it's probably not contributing a lot. Yeah.
- 14:43And then if you get above that threshold, then it may be contributing to many things systematically, for sure, in that localized tissue. And so the way I would think about it is instead of like a linear increase with age, think of it almost like a ramp, right? That gradual, gradual, and then just like exploding upward at some point.
- 15:05And that would vary tissue to tissue. So if someone's at a young age already struggling with joint issues, as an example, it's in all likelihood they've got more senescent cells in that tissue than other people at that age that aren't faced with that struggle or that challenge. But they may have normal amounts of senescent cells in their liver or other tissues. The other tissues may be aging at a more normal level.
- 15:32because we all wear and tear unevenly. And some of that's, you know, genetic, some of it's, you know, other things, diet, lifestyle, but we all have Achilles heels, so to speak. But if a system's aging at an accelerated rate, there's probably more senescent cells in that tissue, no matter the person's age, then you would want at that age. But in general, the way I would think about it
- 15:53is that by my age, the expectation is I would have way more than Greg at age 40. And he'd have had a little bit more than Greg at age 20. And Greg at age 80 should have a lot more. So unless there's a gardener coming in and pruning away, that's just the natural expectation.
- 16:10progression and that we want to, you know, to get back to what you started with. We want to do more and start young. We don't want to manage problems. We want to be a good gardener and make sure we're getting the yellowing leaves early. So what would make sense to me is we would want to prune things maybe when we're 30, 35, late thirties, but maybe we don't need to prune as frequently.
- 16:34where if someone's, you know, 60, 65, you know, already struggling with, say, joint issues, we may want to run more aggressively initially to get the load below that threshold again. So I, when I think of, as we mentioned, like, you know, by my age 30, some things I thought were good investments, like doing yoga and, you know.
- 16:54meditating and exercise and trying to eat sensibly and get enough sleep rather than kick the can till I'm the age of my uncles whose health I don't want to replicate or my dad who died fairly young, I need to be smarter now. So I think of managing senescent cells a bit like that. But for a younger listener on this call, then it would be more like, okay, maybe I would want to do something like I would do a quarterly fast or twice a year detox.
- 17:22Where if you're my age, I do volusenolytic once a month for two days. Okay. Which isn't that big of a time investment, but we'll get into the details of how. Now, you had mentioned, you had brought in the term fasting, and that made me think of autophagy because we always hear that term autophagy when people fast, whether it's an intermittent fast during the day or an extended three-day, five-day, seven-day fast, or
- 17:48we are basically cleaning house. We're cleaning those zombie cells and we're getting them out. We're getting rid of the zombies. Now, how is that different from cellular senescence?
- 17:59Yeah. So that's a great question. So this is going to oversimplify it, but it would be directionally correct. When our cells are stressed, door number one is like, okay, I got this. I'm resilient. I, you know, I can become, I'm tough enough that I can weather the storm. Right? So what you would see on a cellular level is, you know, cell gets stressed, they'll make more antioxidant defenses and other things to become basically fitter and more resilient.
- 18:24But now like there was more stress than they could handle maybe. So some damage occurred and damage inside cells is, you know, mitochondria network got dinged a little bit. Maybe some proteins got misfolded because a lot of what's inside our cells is proteins that get shuttled around. Maybe some organelles, you know, so mitochondria would be an example of an organelle, but there's other organelles as well. Like, you know, the ones that make our genes right in the nucleus. Yeah.
- 18:51Maybe some of those got damaged. And so the next thing is, okay, can I repair the damage? So that would be door number two, right? And so autophagy is door number two. It's specifically, it's about recycling damaged proteins in organelles. You know, so it happens inside cells to basically, let's dismantle these things that are damaged and then recycle and reuse those parts. So autophagy is like, you know, not a whole cell, but like inside cells.
- 19:19So is there a different benefit though, like with autophagy that we get from an extended fast versus addressing the senescent cells? Or is there not a definitive difference? Yeah.
- 19:32Yeah, so what door number three would be, there's been so much stress that the damage isn't repairable. And that becomes cellular senescence because we don't want a damaged cell that's not repairable to make daughter or son cells, right? We don't want it to copy itself and have new damaged cells, right? That would be not sensible, right? So that when it's an unrepairable cell, then it becomes senescent.
- 19:54So one way to think of it is autophagy is like an anti-senescence thing, right? Like you repair the cells so it doesn't have to become senescent. So things that promote autophagy is super important for healthy aging because it means more cells now will go through door number one or two instead of door number three. Okay. But if they do go through door number three, that's really where I'm just kind of trying to bring it into real life so people can understand.
- 20:21That's where the bad cells are replicating. They're making baby cells that are bad. And all of those bad cells stack up to equal cancer. So all these bad cells eventually form a cancer cell or they equate to advanced aging. You know, when you look at someone and you're like, wow, I know that they're 50, but they look like they're 65. Am I getting that right?
- 20:46directionally but there's a couple nuances so think of cancer as its own variety of stress cells okay but ones that have figured out how to make copy after copy after copy right like that's the characteristic of a cancer right is that it just makes new and more cancer cells so it's a different type of stress cell than a senescent cell but instead of a senescent cell not being able to
- 21:15But both ideally should have gone through that falling off process. One of the jobs of the immune system is always to find and remove any stress cells that are lingering. So whether it's a cell that got infected by a virus or a senescent cell or a cancer cell. The immune system we think of as something...
- 21:34for the most visible jobs it does, but a huge part of the immune's job is cleaning up things and keeping us healthy, right? And we know as we get older, there's something called immunosenescence, where the immune system just becomes less good at doing all of its jobs, including finding and removing all types of stress cells.
- 21:52So anyways, the big picture is the senescent cells are a type of stress cells, but cancer would be a very different type of stress cells. And that what autophagy would do is it would prevent cells from getting so stressed that they have to have no choice but to go in those directions. But once a cell has been that stressed, autophagy is not really a solution because it's window of opportunity for what it does would have passed for that particular type of cell.
- 22:20Okay, I'm starting to get this a little bit more. So I guess the big question is, what's in it for me? What's in it for us to pay attention to these senescent cells? And then there is a reason to, which I know you're gonna explain,
- 22:36then how do we do it? Like, how do we get rid of these cells that we don't want in our body wreaking havoc and advancing the aging process of our skin and our joints and muscles and all the things that we see go downhill as we age? Yeah. So most of the research, and this would be true for all kinds of areas, to understand why something's happening are done in animals. And the science of senescent cells and senolytics is relatively speaking new, right? So
- 23:06The first big study was around 2010, and they did gene altering to these animals to make it so that senescent cells didn't accumulate with age, these lingering ones. And what they found was that these animals lived longer and were way healthier. So scientists were like, wow, super cool. These...
- 23:24You know, we've always thought because of the name, you know, senescent cells, senescence having to do with aging cells, that they had some role, but we didn't expect that big a role. So maybe the next big landmark thing was around 2015. Scientists at Mayo and Scripps Institute of Aging identified compounds that when taken orally could help to manage senescent cells, like reduce the load and found the same, like these animals were just way healthier, right?
- 23:50at an older age. So that created just an explosion of interest. Now, all of a sudden, it seemed like, oh, maybe there's something actionable here that we can do. And since that time, senescent cells have been looked at, like as an example with joints, they would have done an experiment where they injected senescent cells into the joints of super, you know, like young mice and rats to see what happens. And what they find is,
- 24:14Really quickly, we create aged joints and all the symptoms that you expect with aged joints. They've looked at what would be muscle tissue and they looked, okay, so they would use the term anabolic resistance as an example. But if listeners have heard of insulin resistance, think of it as somewhat along the same lines. Like they can't grow. Yeah. You can't put on muscle and you're losing muscle essentially. Yeah.
- 24:39Yeah, our muscles aren't responding to the anabolic signals in a way they should. They're resisting it. And anabolic signals would be like weightlifting in a human, right? Or making sure you get adequate protein for listeners, right? We know that's a huge, like super important for everyone in an area that many times average women neglect, right? They don't get enough protein.
- 24:59protein to maintain great quality muscle. So anabolic resistance is something that occurs in older animals that doesn't occur in younger ones, just like in us, you know, our muscles, you know, as we get older would be anabolic resistant. And so scientists were like, why? Like what's contributing to that?
- 25:15And one of the things they identified was it was the accumulation of these zombie cells, the senescent cells that were causing the muscle tissue not to respond anabolically when it should to exercise or more protein. And that what they did in one of these original experiments is they gave two senolytic compounds together, which then removed some of these senescent cells from the old muscle. And lo and behold, they responded to anabolic signals again. Yeah.
- 25:42like a younger mouse muscle tissue would do. So they've looked at many areas, you know, liver health, skin, brain health, pretty much all the things that every listener would know, just observing people as they get older, we see visibly. And we see, you know, like as an example, older people become more frail. They walk slower, like their whole system starts to just wind down. And so...
- 26:09In any area that's been looked at to date in aging animals, senescent cells play a big, big role. So we don't have to go into the details of all of those, but just think of one of the classic ideas of why do we age has to do with an idea that it's because we just accumulate more and more damage.
- 26:27at a cellular level, you know, that's why autophagy gets in a lot of interest. And senescent cells would be clearly in that category of damaged cells, right? They're stressed, they're damaged, and we accumulate more and more of them. So even going back to that original, you know, life expectancy after age 60, healthy life after that, right? Like we want to compress the
- 26:51that window of time to as short as possible. So that longevity scientists would call that compression of mortality. And senescent cells are thought to be one of the things. If we address them, we'd push that window back, you know, so that we'd have healthy years up closer to the end on average. Maybe it wouldn't extend how long we live, but we would, you know, have enjoy more living our years our way.
- 27:18So if we want to, I'm not even going to say age gracefully, like age like a badass, not have joint pain, keep our muscle, keep our skin pulled up and not drooping, not age quickly, keep our brain healthy and alive and alert. Right.
- 27:33We all want that. So in order to do that, this is where the senolytics come in. So that's a whole other term that I'll let you describe. But this is the answer. Senolytics are the answer to slow down that rapid aging process caused by the senescent cells.
- 27:52Yeah, so the term senolytic originated with the Mayo Clinic and some Scripps researchers, and they basically said, okay, what should we call these compounds that look like they help us finally get the zombie cells to kick the bucket? And they decided, okay, we'll just call, you know, sand, right, like is part of it, and it has to do with aging. Lytic has to do with kind of lysis breaking apart. Let's just call this category of things senolytics.
- 28:16And the original two that they put in that category were quercetin, which some listeners may know that's a dietary supplement. That's a flavonoid found in onion skins, as an example. And then a medication called the satinib. And what they found is that,
- 28:35quercetin was a senolytic like an endothelial cell so cells line our arteries and blood vessels and in bone cells as an example in that study but wasn't active in fat tissue when they did that first experiment but that other compound was active in fat tissue and not so good in these other parts of the body and so they had the idea well let's just put both together that's maybe they'll work better and
- 28:59They found that it did, right, that they stacked well. And that combo was more senolytic than either of these things on their own. So that's usually just thought of the D and Q stack. And that's been the most studied combination to date of compounds for senolytic compounds.
- 29:16And then a couple of years later, those same researchers said, okay, well, if quercetin works, maybe some other plant compounds would work as well. And what they found in that case is something called fissetin or fissetin. I hear it both ways. It was even a more...
- 29:32powerful senolytic compound in their experiment than quercetin was. And in that case, it was actually active in fat tissue where quercetin wasn't. So all of a sudden it's like, oh, well, maybe fiscetin and quercetin would be a good combo to start playing with. And then over time, they've identified several other plant-based compounds. And then there's also a big emphasis in the pharma world to see if they can find out things that act as senolytics as well.
- 30:00Oh yeah, well, a big pharma can jump on it, look out. But luckily, it's in the supplemental world right now. So I like that. I like hearing that, that it's staying there for now. So how do these senolytics work and how do we incorporate them in? Because, you know, I mean, supplement fatigue is real.
- 30:20And a lot of people out there, a lot of my listeners out there, my patients included, they just get overwhelmed. Like, oh, one more thing. We're talking about one more thing. But my experience with Semolytics is that you don't have to take this every single day. It's not one more pill that you're adding to your little pill box over and over again. You can take it in blocks. Like you said, well, what I do now is I take my qualia two days a month.
- 30:46Yeah. Yeah. So let's get to how they work. And this is going to really oversimplify things. But at any point in time, like a cell has basically decided, I'm not going to die or I am going to die, right? I'm either going to stay and keep doing my job or I'm going to go through apoptosis, right? And the way I would think of that, it's almost like a vote in system.
- 31:07And as long as it's 51, like I'm going to stay, verse 49 saying I'm going to go through apoptosis, then this cell will stay. And so what was really a kind of a cool idea, or I think a cool part of the thought process of the original Mayo researchers was...
- 31:26The characteristic of these senescent cells is they're resisting apoptosis. The vote's basically in favor of hanging around. Even though this cell is worn out and stressed and not doing a good job and should have gone through this, the voting system's just mucked up somewhere along the line.
- 31:44So, you know, what do we know about the voting system? What how does that voting system work? Right. And at the hub would be what are often thought of as pro and anti apoptotic proteins. So that's a fancy word. But just thinking the final voters like voting day or go. But then what influences those voters is all kinds of things. But one of those is classically thought of as nutrient sensing.
- 32:06The cell listening to the world around it, what are the messages it's getting and how are those impacting these nutrient sensing pathways? And an example of a nutrient sensing pathway I know you would know about is mTOR, right? Like that would be a nutrient sensing pathway that's specific for proteins. Yeah.
- 32:24as an example, but there's other nutrient sensing pathways. And one of those is where things like the quercetin, the fiscetin, some other flavonoids like luteolin work. They seem to shift how cells sense the environment and then the messages that the cells send to the voters at the end of the day.
- 32:44And so they kind of correct that whole system in a way that finally gets the cell to decide, oh, I get it. There's no reason for me to hang around anymore. I can finally go through this natural falling off process. So these plant-based ones, many of them work there, right? They're just kind of influencing the end voters in ways that allow the cell to finally go through the normal process it always should have gone through.
- 33:08And then you asked about the frequency. And so going back to that original D and Q stack, you know, quercetin has been used. I've been a naturopathic doctor, you know, coming up on 30 years. And quercetin was being used by naturopaths and functional medicine MDs before that, even right, it's very safe. But the D part of it is a really potent medication that has, you know, can have negative effects on the immune system, if not used in the right way. Yeah.
- 33:38And so the Mayo researchers at the time said, OK, well, all we need to do is change the voters mind once.
- 33:44We don't need to change it every day, every day, every day. We just need for that particular cell to change it once, then that cell will finally toggle into this falling off process and we're good. And so maybe instead of doing it every day, like some of the listeners maybe are on thyroid medications or insulin or hormones or female hormones, you name it, right? Those things generally you're doing every day, right? Because you need to be impacting that system on a continuous basis.
- 34:13But this, it was more like, oh, we just need to normalize it once, right? D's got really good medical uses. But in this use, maybe instead of doing every day, it would be safer just to do it intermittently. So from the get-go, they said, okay, let's just do this hit-and-run approach.
- 34:30Just try to change the voters' minds once and then give a vacation from it. And then we'll do it again to maybe get more senescent cells the next go around. And their thought process was basically, this looks like the best risk reward to do, right? Rather than more aggressively. So almost baked in from the beginning was this idea of intermittent use.
- 34:51of senolytic compounds and in large part because of the D part. But I still think that's the best way to approach even the plant-based ones, because I don't know if this would make sense to you, but one of the big, I guess, things that people don't understand is that our senses aren't designed to detect quantities of things. They're designed to check or to see or hear how quantities change. Can you explain that more? Yeah.
- 35:17Yeah. So like like an analogy, imagine going into the darkest closet in your home for any of the listeners and not lighting one candle. Your eyes would notice a big difference. Now imagine going into that same closet and there's ninety nine candles lit and you light one more like maybe notice no difference. Right. Right.
- 35:34Right, okay. So one candle doesn't matter. It's like the proportion of change, right? From a completely dark one candle, huge response. From well-lit one candle, maybe nothing, right? So all senses, and it's why hearing is a log scale.
- 35:50Like decibel system, you've probably heard of from hearing, that's not a linear thing. It's an exponential log scale. So to go from 60 to 70 decibels is a lot less noise than to go from 70 to 80 because it's a log. And the reason they did that is because scientists have known since the 1800 that our senses respond to proportional change, not to quantities.
- 36:16And so my assumption is the receptors on our cells work on the same principle. Like, why wouldn't they? Right. They're sensing their environment just like our eyes and ears are sensing ours. Right. And so the reason that becomes important is doing senolytics two days a month, you're creating a massive change. You're doing much more like walking into a dark closet and lighting a candle. Right.
- 36:39Where if you were doing the same thing every day, every day, and listeners would know this, right? If you hold noise unchanging, background noise, our brain will really quickly ignore it. Mm-hmm.
- 36:51Right. So they could like being in a restaurant that there's a lot of background noise really quickly. We tune out all of that. Right. And we'll be hearing the people talking to us. But now imagine, you know, a table nearby. Someone says, Greg, I'll hear that. Right. Yeah. Because that will get my attention. It stood out from the noise. Right. So the scientists would call that signal to noise. But.
- 37:14By doing something continuously all the time, we're making it so that it's a big signal is less likely to stick out. But by doing something intermittently, we're more likely to notice it. So I also think that's why the frequency can be more variable. I mentioned earlier, if I was young, maybe I would do this once a quarter. But that's why once a month.
- 37:39I'm taking a massive dose of fisetan and quercetin and some of these other things. My cells aren't going to miss that signal. Where if I was taking a lower amount every day, at some point it's like, oh, I heard the same signal yesterday. The day before, like, who cares? Right. And since we're trying to work on nutrient sensing pathways, I think it just makes a lot of sense to create this big change just a couple days a month, as an example. Yeah.
- 38:07And very easy to do as a user, as a consumer, super easy to do just a couple of times a month. It just reminds me of the bioregulators, that you really only have to use those 10 days a month to elicit a change to that system, that organ, whatever you're hitting with the bioregulators. So this sounds very, very similar to that.
- 38:27I mean, not similar in the lines of bioregulators, but similar in the dosing that you don't have to commit to a daily dose. All we have to do is take it, what, once a month? Is that for everybody or who actually should use Senolytics? I mean, we talked about pretty much anyone over the age of 40, maybe some people in their 30s. But after the age of 40, we really should be using this monthly.
- 38:50Yeah. So we've done a couple of studies at Qualia, including one with a placebo group. And what we did for that, all those studies to date, is we recruited people with some degree of joint issues. We didn't care about the age, right? They could be, say, 35 to 70, as long as they were already having some issues with flexibility, discomfort, activities of daily living.
- 39:12And what we did for those studies, in part, initially, just like, okay, you know, how can we get the most people to complete a study? We had people take two days on, 12 days off, two days on, 12 days off, two days on. So over five weeks, they would have taken Kuala-Cenolidec for six days.
- 39:29with a vacation 12 days in between each. And what we saw in those two studies was about a 65% improvement in how their joints performed, right? So a big change with that intermittent thing. So that would be almost the smallest window of intermittent timing that we've experimented with.
- 39:49Now, I know some people on their own that are having many more issues that their doctor said, you know, Greg, can I give them this every weekend and just five days off? Which I'm sure like experiment with that. Let us know what you see. For me, I'm not experiencing anything that I would notice. My joints feel great for my age. I don't have anything other than what I would think is I'm trying to just invest in making sure I keep things below the threshold. So for me, it makes more sense.
- 40:19as an example. So that's kind of our default recommendation and what we have the most data on is people doing it once a month. For a younger person who I would expect in general to have even fewer, then it would make more sense to me to do even a bigger recommendation
- 40:34gap between cycles. And that's why I said earlier, if I was 30, 35 and wanted to start, you know, experimenting here, I would probably just, you know, once a quarter might be sufficient. So kind of just depends where someone is on that continuum. But, you know, for most listeners, I would say, you know, just default to what I do and what most of our users have done, which I always do, the Mike, while you're seeing a Ledeck the first weekend of every month, it's,
- 41:00Easy. Those days, I don't do any other supplements. I just take these few things and then I'm good for the month. And then, you know, the goal is just to gradually make sure that we prune away more and more over time, right? And, you know, then I think that pruning analogy also makes sense because what would happen if you pruned a plant every day?
- 41:20Yeah, I wouldn't like it that much. That's true. You can't get down to nothing, right? You'd prune it away to nothing. Yeah, we'd kill it, right? So like a good gardener only prunes periodically. So that's also like another way just to think of things like senolytics or qualea senolytic. Like you're just, you know, you're doing something that's acting as the gardener or supporting pruning and you don't need to do that.
- 41:43all the time, all the time. In fact, you want to make sure you have gaps between each pruning session. So to aggressively prune away things.
- 41:52And I love this whole topic of doing things to anti-age, doing things now. And my audience knows that I'm not the type like Dave Asprey who wants to live to 150. I'll take 80 to 90, but just living really, really well and feeling great. So the fact that I can do something just once a month
- 42:14a couple of days a month and invest into my future self and my aging future self, I think it's a no brainer. And that's really, I mean, when I started looking into this world of Senolytics, Qualia was the only company that I found who, you know,
- 42:30dives into this research and that produces a high quality senolytic. I don't even know if there's another company out there, but that's why I wanted you on the show is to dive into the science so that I could understand it better. And my audience could understand it better because it's one thing to say like, okay, well, you're taking these things to help you,
- 42:49anti-age, but you only have to take it a couple of times a month. So I'm happy that you're kind of getting into the explanation and it makes it really easy. Is Qualia the only company? I mean, that's the only one that I know of that really has dove into the study of senolytics and cellular senescence.
- 43:07Yeah, I've seen a few other brands play lip service to Cenolytics, but I think like there's a couple, we talked about that idea of hit and run dosing, right? Like that idea, it's for some of these things, we want to do it intermittently. I've seen companies say, oh, like we've got Visetin in our stack of things to like handle cellulose senescence. So you're covered, like we've got this Walmart covered for you. Yeah. And it's, you know, and take Visetin every day. Like that's not.
- 43:33One, that's not how senolytics work mechanistically, right? It's that we want to create that massive change. To extrapolate from the animal studies where the Mayo researchers first gave fisetin and what they've been using in human studies is 20 milligrams per kilogram of body weight, right? So...
- 43:51You know, for a 150-pound person, that would be about 1,500, 1,600 milligrams of fisetin, not 100 milligrams, right? Again, going back to our candle analogy, like that would be like lighting one candle versus 16 candles. Is that likely to make a difference? Yes.
- 44:07Yeah, right. And, you know, so something can be a senolytic compound, but if you don't get enough of it, it's not likely to do something. And the analogy I would just use in my brain is like, we all know saunas can be a really useful tool, right, to keep us healthier, part of our longevity profile. And, you know, the key thing there is temperature, right? You know, so if we go into a sauna and the temperature is set to 60, is it really a sauna? Yeah.
- 44:34Right. Right. If it's 140, 160, yes. Right. So the same, like bisetan at 100, is that really, you know, like a senolytic? No. And then the last thing goes to that original Mayo work where they decided, let's stack D and Q together. Something could be senolytic, but that didn't mean it was equally active in all tissues. In fact, they found that things were not active.
- 44:59So we at Qualia think it's important to stack multiple potential senolytic compounds together that collectively support a broader range of tissues. So one of the things we have is...
- 45:14which is a compound found in Ayurvedic plant called long pepper. Think of it as a relative of black pepper, but one that we don't use in our country. And that in Ayurveda would have had an affinity for organs like the lungs and the kidneys.
- 45:29As an example, you know, curcumin, we, you know, many listeners might know of curcumin for joints. Olive leaf extract also has an affinity for joints. There's a proprietary blend of noto ginseng and sweet chestnut, which is called Senactive. And Senactive has been studied for muscle tissues, for senescent cells. So one of the things when we were creating Quilocynolytic, we wanted to make sure we had a portfolio of ingredients that supported multiple different ingredients.
- 45:58tissues because something can be a senolytic like fisetin, but it doesn't mean it's going to broadly support every tissue you need it in. So we just think it's better and smarter to do this portfolio approach. Yeah, no, I totally agree. And I'm so happy that I found Qualia and found your company to be able to use. Now, just like you, I use it for more prevention. There's not something going on with me that I want to see change.
- 46:25But let's say someone has joint issues or someone, and I hear this from my community and from my patients too, that anabolic resistance. You know, my ladies are like, I'm lifting heavy. I'm doing the protein. I'm getting asleep. And my muscles just aren't growing. So, of course, we look at testosterone and thyroid and hormone balance, how much protein are you taking in, all of that. But if someone is really experiencing this disease.
- 46:49anabolic resistance at the muscle level, how many months of using a senolytic will it take for them to see, oh, now I'm getting a bang for my buck at the gym?
- 47:01Yeah, I think it's going to vary kind of, again, like, you know, are you above the threshold below it? How far below? But I would say in general, give it at least three months. Like one of the things I looked at, you know, so my first career before a naturopathic doctor was I was an officer in the Navy, you know, for when inactive due to 84 and got out in 89 and spent most of that five years sleep deprived, body clock disruption, not a great diet because eating Navy chow, you know, in a.
- 47:28pretty toxic environment, I went through two overhauls, which you're in a shipyard exposed to like metals and fumes and you name it. Right. Right. So, and plus I was not, I was more a part of your lifestyle, that younger version of Greg until he became a better investor. And, you know, so that contributed, right. And to accommodate kind of, to try to balance things out, I exercised way more then than I did now, but I didn't allow anywhere near as much recovery time as I would
- 47:58Intuition is that I probably built up, despite thinking I was healthy, built up a lot more senescent cells than I should have because my life was so out of balance in so many ways. Yeah. Right. And I've never been genetically a big gainer for lifting weights. I'm more that I would have been a cross-country runner built in high school. Right. Right.
- 48:19So for me, it was one of the things I paid attention to was I track all my lifting workouts. I personally use the X3 bar for people that might be familiar with that heavy straps. And I felt pretty plateaued for a while and had been doing different things to work around that. But that's what I paid attention to. And I got unstuck pretty quickly when I started taking quality of senolytic. But it's going to, you know, it's so individual, right? But that's something I paid attention to. Another area I mentioned was joint comfort.
- 48:47One of the things that's really clear about senescent cell accumulation in fat tissue in animals is it contributes really strongly, not necessarily to the number of fat cells, but to all the metabolic bad things they do, right? Insulin resistance and blood sugar issues and things like that. So, you know, someone's already struggling with those, like pay attention to those kinds of things.
- 49:09And then, you know, old injuries, right? Or I used to do a lot of trade shows. I worked for a company called Thorne, right, when I graduated naturopathic school and used to do a lot of trade shows on the circuit back in the 90s, early 2000s. And even back then, closer to maybe late 30s, or so back then, I would feel it in my knees and lower back by the end of, you know, a day or two standing on trade show floors.
- 49:32And I don't do very many trade shows. We just don't do that many. We do Dave's biohacker event. We're going to be at Eudaimonia. So I do a few. But Dave's recent event in Dallas, I noticed that the end of the first day, the end of the second day, my back was so much better. My knees are so much better than they had been 24 years ago.
- 49:53When you were younger. Yeah. Yeah. And I, I don't know what else to attribute that to, right? Like that's to me, it seems like those have always been, I know, like when I get, you know, some stress, some low level inflammation, that's where it seems to be felt. And it just wasn't felt as strongly. So, but I think we're all different, right? So we just have to pay attention. And then, like I said early on, like I didn't go into taking choleosinolytic expecting to notice any changes. Cause I wouldn't have said, Oh, I'm feeling, yeah.
- 50:21a bunch of things. And, you know, so some other things like we've noticed a fair amount of people say, oh, like my energy levels, right? It seems to be doing something in their brain. Then that's an area we're looking more into. We've had that I know of. So think of this as completely end of one. Listeners may not have any relationship to quality synalytic, but we've had
- 50:42Six women, including the head of our customer service, that all had stopped menstruating and started menstruating again at some point after taking quiescentalytics. So it seemed like for those women, for that to happen, something with ovarian aging. Yep. Yeah. Yeah.
- 50:59So again, maybe unrelated, but we've now accrued enough of those people calling in and saying, hey, like this happened. Has anyone else said it happened? That's like, okay, this is starting to seem interesting. So, you know, so I would just say, hey, broadly, you know, anything that tends to be interesting.
- 51:17your Achilles heel or might be related to an aging thing, but particularly a system of your body that is the Achilles heel or that you have suspicions may be aging at a little faster rate because we all have those.
- 51:33We do. We do. And you guys made a killer product to be able to help this and help all of us. So that's what I wanted you on. Thank you for unpacking this because I was admittedly confused about the Senneletics. Well, interested in, but did not have all the information, data and
- 51:52Rather than going and digging for it, I thought I'd just ask an expert because that's so much easier, so much easier. So to me, this is a no brainer to add in Qualys analytic is a no brainer. You're doing it a couple days a month.
- 52:07And why not? You know, why not? Why not add it in? And you guys are even giving my audience a discount. So if you go, we'll put the link in the show notes and try it out for yourself. And really, like Greg said, give it a good run. Give it a good three months, whether you're looking at changing joint pain or getting those muscles back that many of you are struggling with. That's what we were talking about earlier. Or just even improvements in skin or your brain.
- 52:33I don't know how many women out there want their period back, but you never know. So I would say absolutely give it a couple of months of use. But to me, this is a no brainer in the arsenal of anti-aging. Yeah, I tend to think the same. Like I take a portfolio approach to my health, same way I do to my financial wellness. And I just consider this, you know, at least at this point, given what we know, a really promising and easy investment for me to make.
- 53:01I agree. I totally agree. Well, thank you for your knowledge and explaining everything today. It's just helped tremendously. It's helped me and I know it will help my audience as well, just to understand this whole aging process a little bit better and what we can do about it. My pleasure. Thank you so much for having me on today.